Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris

Boris Duchemann(Université Paris Cité), Isabella Annesi‐Maesano(Inserm), C. Jacobe De Naurois(l'Assurance Maladie), Shreosi Sanyal(Inserm), Pierre‐Yves Brillet(Université Paris Cité), Michel Brauner(Assistance Publique – Hôpitaux de Paris), Marianne Kambouchner(Assistance Publique – Hôpitaux de Paris), Sophie Huynh(Centre hospitalier Robert-Ballanger), Jean Marc Naccache(Sorbonne Université), Raphaël Borie(Assistance Publique – Hôpitaux de Paris), J. Piquet(Groupe Hospitalier Intercommunal Le Raincy Montfermeil), A. Mékinian(Assistance Publique – Hôpitaux de Paris), Jerôme Virally(Centre hospitalier Robert-Ballanger), Y. Uzunhan(Université Paris Cité), Jacques Cadranel(Sorbonne Université), B. Crestani(Assistance Publique – Hôpitaux de Paris), Olivier Fain(Assistance Publique – Hôpitaux de Paris), François Lhote(Centre Hospitalier Saint-Denis), Robin Dhôte(Assistance Publique – Hôpitaux de Paris), Nathalie Saidenberg-Kermanac’h(Assistance Publique – Hôpitaux de Paris), Paul-André Rosental(Institut d'Etudes Politiques de Paris), Dominique Valeyre(Université Paris Cité), Hilario Nunès(Université Paris Cité)
European Respiratory Journal
August 1, 2017
Cited by 296Open Access
Full Text

Abstract

The objective of the study was to estimate the prevalence and incidence of interstitial lung diseases (ILDs) in Seine-Saint-Denis, a multi-ethnic county of Greater Paris, France. Patients with ILDs were identified between January and December 2012 by using several sources; all potentially involved medical specialists from public and private hospitals, community-based pulmonologists and general practitioners, and the Social Security system. Diagnoses were validated centrally by an expert multidisciplinary discussion. 1170 ILD cases were reported (crude overall prevalence: 97.9/10 5 and incidence: 19.4/10 5 /year). In the 848 reviewed cases, the most prevalent diagnoses were sarcoidosis (42.6%), connective tissue diseases associated ILDs (CTDs-ILDs) (16%), idiopathic pulmonary fibrosis (IPF) (11.6%), and occupational ILDs (5.0%), which corresponded to a crude prevalence of 30.2/10 5 for sarcoidosis, 12.1/10 5 for CTDs-ILDs and 8.2/10 5 for IPF. The prevalence of fibrotic idiopathic interstitial pneumonias, merging IPF, nonspecific interstitial pneumonia and cases registered with code J84.1 was 16.34/10 5 . An adjusted multinomial model demonstrated an increased risk of sarcoidosis in North Africans and Afro-Caribbeans and of CTDs-ILDs in Afro-Caribbeans, compared to that in Europeans. This study, with a comprehensive recruitment and stringent diagnostic criteria, emphasises the importance of secondary ILDs, particularly CTDs-ILDs and the relatively low prevalence of IPF, and confirms that sarcoidosis is a rare disease in France.


Related Papers

No related papers found

Powered by citation graph analysis